PANoptosis in life and death across cell types: From innate immunity to therapeutic implications
Cell Chemical Biology · 2026-07 · 33 (7) · 1021-1037
DOI: 10.1016/j.chembiol.2026.06.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Chemical Biology, 2026-07. Verfasst von Kristine E Zengeler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Immunity, Innate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Innate immune cell death is a fundamental mechanism used by organisms to respond to perturbations, including infection, tissue damage, and cancer. However, excessive cell death can be inflammatory and cause pathology. PANoptosis has emerged as a distinct, lytic, inflammatory cell death pathway initiated by innate immune sensors and driven by caspases and receptor-interacting protein kinases through multiprotein PANoptosome complexes. Genetic, biochemical, and imaging evidence initially identified PANoptosis in macrophages but now indicates that it operates across diverse immune, non-immune, and cancer cell types, where it drives host defense, inflammation, and pathology. In this review, we critically evaluate current evidence for PANoptosis as a unique and central cell death pathway across cell types and disease contexts, elucidating the key molecular mechanisms that govern its activation. We discuss emerging insights into PANoptosome biology, the physiological and pathological functions of PANoptosis, and how cell type-specific regulation shapes disease outcomes. Finally, we highlight the therapeutic opportunities and challenges associated with the cell-selective modulation of PANoptosis to improve treatment of infectious, inflammatory, and malignant diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: thirumala-devi.kanneganti@stjude.org.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- American Lebanese Syrian Associated Charities
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Zengeler, K. E., Tweedell, R. E., & Kanneganti, T. D. (2026). PANoptosis in life and death across cell types: From innate immunity to therapeutic implications. Cell Chemical Biology, 33(7), 1021-1037. https://doi.org/10.1016/j.chembiol.2026.06.007
Vancouver
Zengeler KE, Tweedell RE, Kanneganti TD. PANoptosis in life and death across cell types: From innate immunity to therapeutic implications. Cell Chemical Biology. 2026;33(7):1021-1037. doi:10.1016/j.chembiol.2026.06.007
BibTeX
@article{Zengeler2026,
author = {Zengeler, Kristine E and Tweedell, Rebecca E and Kanneganti, Thirumala-Devi},
title = {PANoptosis in life and death across cell types: From innate immunity to therapeutic implications},
journal = {Cell Chemical Biology},
year = {2026},
volume = {33},
number = {7},
pages = {1021--1037},
doi = {10.1016/j.chembiol.2026.06.007}
}
EUVIMED